Hepatitis B News

 
 
  • WHO Issues Its First List of Essential Diagnostic Tests The Essential Diagnostics List is a catalogue of the tests needed to diagnose the most common conditions as well as a number of global "priority" diseases.
  • NCCN 2018NCCN: Screen for Liver Cancer in Patients at Risk Hepatocellular carcinoma is a 'bad actor' with a growing death toll in the United States and Europe; when possible, patients with risk factors should be screened.
  • ACIP Recommends Heplisav-B Vaccine for Adults Heplisav-B, a yeast-derived hepatitis B vaccine made with a novel adjuvant, is recommended for individuals aged 18 years and older, according to the Advisory Committee on Immunization Practices.
  • ILC 2018Liver Cancer on the Rise in Backdrop of Undiagnosed Hep C The hepatitis C epidemic that started in the 1950s infected many patients who are now developing end-stage liver cancer, and the number of cases is growing, researchers report.
  • Almost 300 Million Worldwide May Be Infected With HBV About 292 million people worldwide may be infected with hepatitis B virus (HBV), a new modeling study shows.
  • Resection Bests Chemoembolization in Selected Liver Cancer Patients Resection offers survival benefits in carefully selected patients with intermediate-to-advanced hepatocellular carcinoma (HCC), researchers in Korea suggest.
  • Alcohol-Related Liver Cancer Diagnosed at Later Stages Liver cancer related to alcohol consumption is assosciated with worse outcomes than other types of liver cancer, primarily owing to later diagnosis.
  • Tenofovir Fails to Add Extra Hepatitis B Protection for Vaccinated Newborns Adding tenofovir disoproxil fumarate (TDF) to an aggressive treatment strategy fails to give extra protection to newborns at risk for contracting hepatitis B virus (HBV) from their infected mothers, according to a study at 17 public hospitals in Thailand.
  • Alert ACIP Issues 2018 Child and Adolescent Vaccine Schedule Recommendations clarify who should get a third dose of the mumps vaccine and highlight that the hepatitis B vaccine should be given to all nonpremature babies within the first 24 hours of life.
  • Hep B Reactivation Common During Direct-acting Antiviral Therapy for Hep C Hepatitis B virus (HBV) reactivation is common in patients with chronic HBV and hepatitis C virus (HCV) coinfection receiving direct-acting antiviral (DAA) therapy, according to a systematic review and meta-analysis.
  • Best Practice Testing Failed to ID Hidden HCV Infections A best practices HCV and HBV testing strategy failed to find hidden HCV infections, a study found. This approach may not work in low-prevalence countries.
  • Hepatitis B Vaccination Rates Subpar in Patients With HIV More than a third of patients with HIV infection fail to get hepatitis B virus (HBV) vaccination, despite a longstanding recommendation, report researchers from the Centers for Disease Control and Prevention (CDC) in Atlanta.
  • Elevated Liver Cancer, Death Rates With Chronic HBV Patients with immune-tolerant-phase chronic hepatitis B virus (HBV) infection, who are usually not considered for treatment, face an increased risk of hepatocellular carcinoma (HCC) and death, compared with treated immune-active-phase patients, researchers from Korea report.
  • In US, 4 out of 10 Cancers Could Be Prevented Potentially modifiable risk factors account for a large proportion of all cancer cases and cancer-related deaths in men and women living in the US.
  • Clinical Guideline on HBV Released by ACP, CDC The American College of Physicians (ACP) and Centers for Disease Control and Prevention (CDC) advise vaccination and screening of adults at risk for HBV, including those who are unvaccinated, and linkage to care for infected individuals.
  • Lab Screening of Kids Entering Foster Care May Have Low Yield Laboratory screening for infectious diseases in children entering foster care yields few results that are clinically meaningful, researchers report.
  • Alert Heplisav-B Vaccine for Hep B Finally Wins FDA Approval Rejected twice before by the agency, the new vaccine must undergo a large postmarketing study on the risk for acute myocardial infarctions and immune-mediated diseases.
  • AASLDProgress in Fatty Liver and Pediatric Liver Disease New findings on nonalcoholic steatohepatitis, pediatric liver diseases, hepatitis B, and the microbiome will be among the topics tackled at the upcoming Liver Meeting.
  • Incidence of Liver Cancer Rising in Most Areas of the World The global incidence of liver cancer has climbed by 75% over the last 25 years, but the main causes of liver cancer vary widely among geographic regions and to some extent by income.
  • ICVHHepatitis Barriers to Care Focus of ICVH 2017 Efforts to improve screening for hepatitis C and access to treatment, especially for high-risk populations, will be in the spotlight at the upcoming International Conference on Viral Hepatitis (ICVH).